Robert Dee Etherington
Chief Executive Officer at CLENE INC.
Net worth: 32 726 $ as of 2024-04-29
Robert Dee Etherington active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CLENE INC. | Director/Board Member | 2019-12-31 | - |
| Chief Executive Officer | 2013-03-31 | - | |
| President | 2013-03-31 | - | |
| BioUtah | Director/Board Member | 2016-05-31 | - |
Clene Nanomedicine, Inc.
 Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Director/Board Member | - | - |
| Chief Executive Officer | 2013-03-31 | - | |
| President | 2013-03-31 | - | |
| Corsair LLC | Director/Board Member | 2018-02-28 | - |
Career history of Robert Dee Etherington
Former positions of Robert Dee Etherington
| Companies | Position | Start | End |
|---|---|---|---|
Actelion Pharmaceuticals Ltd.
 Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The company is based in Allschwil, Switzerland. | Sales & Marketing | 2000-08-31 | 2013-02-28 |
Training of Robert Dee Etherington
| Brigham Young University | Masters Business Admin |
Statistics
International
| United States | 6 |
| Switzerland | 2 |
Operational
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| President | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CLENE INC. | Health Technology |
| Private companies | 4 |
|---|---|
| BioUtah | |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Health Technology |
Actelion Pharmaceuticals Ltd.
Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The company is based in Allschwil, Switzerland. | Health Technology |
| Corsair LLC |
